KNOXVILLE, Tenn. (AP) -Former Tennessee guard Chris Lofton underwent treatment for testicular cancer after a failed drug test revealed he potentially had a tumor.
Lofton revealed to that he underwent surgery in March 2007 and had four weeks of radiation starting in May.
Lofton was randomly picked during the 2007 NCAA tournament for a drug test that revealed he had high levels of a hormone that serves as an indicator of steroid use or cancer.
The Southeastern Conference's 3-point record holder said in a statement released Thursday that it was a difficult time for him but he's now cancer-free.
Coach Bruce Pearl said Lofton and his family had wanted to keep information about his cancer private throughout the season. Team officials declined to comment further about Lofton's condition, citing HIPPA medical privacy laws.
Lofton was The Associated Press' SEC player of the year as a junior and a second-team All-American. He was a preseason All-American going into his senior season.

NCAAB Headlines

More inNCAAB News  

NCAAB Top Stories

Thumbnail 2017 NCAA Title Odds Fresh off its first Sweet 16 berth in three years, Indiana seems to be trending back in the right direction under coach Tom Crean. This fall, though, will challenge the...
Thumbnail 2017 NCAA Title Odds George Washington named Maurice Joseph its interim head men’s basketball coach last week. Will the 31-year-old be able to keep the Colonials humming in 2016-17?
Thumbnail 2017 NCAA Title Odds Villanova always understood the myriad challenges of defending a national title. Yet the program definitely couldn’t have foreseen Friday’s bit of bad news.
More inNCAAB Articles  

NCAAB Team Pages